ReviewFrontiers in public health2026
Towards the One Exposome: harnessing artificial intelligence and digital health technologies across One Health toxicology, new approach methodologies, and environmental public health.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The One Exposome framework integrates exposomics, One Health toxicology, New Approach Methodologies (NAMs) and artificial intelligence to advance environmental health from reactive risk assessment towards predictive, preventive, and participatory science. The paper positions One Health as the ethical and conceptual rationale for recognizing the interdependence of human, animal, and environmental health, the Exposome as the framework for measuring cumulative and life-course exposures, and NAMs together with digital and AI-enabled tools as the means to generate, integrate, and interpret mechanistic and adverse outcome pathway (AOP)-based evidence across biological scales. In this review, environmental health challenges such as antimicrobial resistance, endocrine disruption, and other complex multi-stressor exposures cannot be adequately addressed through compartmentalized, single-substance, or purely retrospective approaches. The One Exposome paradigm instead proposes a systems-based model that links exposure data, mechanistic toxicology, and public health intelligence across humans, animals, and ecosystems. It draws on human-relevant NAMs, including microphysiological systems, together with AI and multi-omics approaches, to support cross-species interpretation, earlier hazard identification, and more preventive intervention strategies. Within this framework, sentinel surveillance, integrated monitoring, and interoperable data systems are central for detecting shared risks across environmental, veterinary, food, and human health domains. The approach is also presented as requiring governance reform so that agricultural practice, environmental management, and clinical stewardship are aligned within a common preventive and planetary health perspective. Overall, the paper frames the One Exposome as a transdisciplinary architecture for environmental public health that combines measurable environments, mechanistic understanding, and computational integration. By connecting cumulative exposures to biological responses and population-level consequences, it offers a foundation for more anticipatory, equitable, and scientifically integrated environmental health decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.